We are live on ! Find out more
AIA

Avalon Investment & Advisory Portfolio holdings

AUM $3.65B
1-Year Est. Return 0.47%
This Fund
S&P 500
This Quarter Est. Return
+14.71%
1 Year Est. Return
+0.47%
3 Year Est. Return
+93.46%
5 Year Est. Return
+123.08%
10 Year Est. Return
+366.85%
AUM
$4.91B
AUM Growth
+$407M
Cap. Flow
-$140M
Cap. Flow %
-2.86%
Top 10 Hldgs %
26.53%
Holding
358
New
36
Increased
134
Reduced
146
Closed
25

Top Sells

Rank Stock Value
1
NOVA
Sunnova Energy
NOVA
+$58M
2
BABA icon
Alibaba
BABA
+$29.2M
3
ALB icon
Albemarle
ALB
+$24.1M
4
CVX icon
Chevron
CVX
+$19.1M
5
NOC icon
Northrop Grumman
NOC
+$12.9M

Sector Composition

Rank Sector Weight
1 Technology 23.08%
2 Consumer Staples 14.57%
3 Healthcare 13.17%
4 Financials 12.93%
5 Industrials 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KHC icon
326
Kraft Heinz
KHC
$30B
$218K ﹤0.01%
+6,296
New +$204K
RSP icon
327
Invesco S&P 500 Equal Weight ETF
RSP
$99.1B
$212K ﹤0.01%
+1,660
New +$197K
IGSB icon
328
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.3B
$204K ﹤0.01%
3,696
-183
-5% -$10.1K
MAIN icon
329
Main Street Capital
MAIN
$5.48B
$202K ﹤0.01%
+6,259
New +$192K
PSXP
330
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
$200K ﹤0.01%
7,583
-1,532
-17% -$39.9K
PAA icon
331
Plains All American Pipeline
PAA
$16.1B
$189K ﹤0.01%
22,982
+3,990
+21% +$30.3K
MRO
332
DELISTED
Marathon Oil Corporation
MRO
$167K ﹤0.01%
25,000
NMFC icon
333
New Mountain Finance
NMFC
$732M
$128K ﹤0.01%
+11,250
New +$121K
BIO icon
334
Bio-Rad Laboratories Class A
BIO
$9.42B
-4,969
Closed -$2.56M
BMRN icon
335
BioMarin Pharmaceuticals
BMRN
$12.4B
-5,621
Closed -$428K
BR icon
336
Broadridge
BR
$19B
-12,581
Closed -$1.66M
CVCO icon
337
Cavco Industries
CVCO
$4.55B
-8,184
Closed -$1.48M
EOG icon
338
EOG Resources
EOG
$70.7B
-7,872
Closed -$283K
EW icon
339
Edwards Lifesciences
EW
$51.7B
-3,109
Closed -$248K
FMX icon
340
Fomento Económico Mexicano
FMX
$41.7B
-12,528
Closed -$704K
LKFT
341
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
-3,901
Closed -$554K
INCY icon
342
Incyte
INCY
$24.4B
-4,816
Closed -$432K
NBIX icon
343
Neurocrine Biosciences
NBIX
$16.6B
-3,804
Closed -$366K
NOMD icon
344
Nomad Foods
NOMD
$1.68B
-123,887
Closed -$3.16M
NTES icon
345
NetEase
NTES
$84.7B
-9,630
Closed -$876K
OLLI icon
346
Ollie's Bargain Outlet
OLLI
$4.94B
-45,110
Closed -$3.94M
PUK icon
347
Prudential
PUK
$35.2B
-22,824
Closed -$633K
RVTY icon
348
Revvity
RVTY
$12.8B
-28,093
Closed -$3.53M
SAP icon
349
SAP
SAP
$238B
-18,487
Closed -$2.88M
TEAM icon
350
Atlassian
TEAM
$37.8B
-7,351
Closed -$1.34M

Similar funds

Avalon Investment & Advisory's Q4 2020 Portfolio in Review

As of Q4 2020, Avalon Investment & Advisory held 358 positions worth $4.91B, up 9% from $4.5B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Avalon Investment & Advisory's Q4 2020 filing shows 36 new, 134 increased, 146 reduced and 25 closed positions. Its largest new stake was State Street Energy Select Sector SPDR ETF: 3,005,420 shares worth $57M. The largest sale was Sunnova Energy, an estimated $58M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Consumer Staples and Healthcare.

  • Avalon Investment & Advisory's largest Q4 2020 buy was State Street Energy Select Sector SPDR ETF: 3,005,420 shares worth $57M.
  • Avalon Investment & Advisory added most to ConocoPhillips in Q4 2020, an estimated $13M increase.
  • Avalon Investment & Advisory's biggest Q4 2020 reduction was Sunnova Energy, cutting an estimated $58M.
  • Avalon Investment & Advisory fully exited Ollie's Bargain Outlet in Q4 2020, selling an estimated $3.94M.
  • Avalon Investment & Advisory's ten largest holdings make up 27% of its $4.91B portfolio in Q4 2020.
  • Avalon Investment & Advisory opened 36 new positions and closed 25 in Q4 2020.
  • Avalon Investment & Advisory's portfolio value rose 9% quarter-over-quarter to $4.91B.

Based on Avalon Investment & Advisory's 13F filing for Q4 2020, filed 8 Feb 2021.